COMPARISON OF QUALITY-OF-LIFE (QOL) OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIAS (AML) IN LONG-TERM FIRST COMPLETE REMISSION (CR) AFTER BONE-MARROW TRANSPLANTATION (BMT) - ALLOGENEIC OR AUTOLOGOUS - OR INTENSIVE CHEMOTHERAPY CONSOLIDATION (ICC) - EORTC-GIMEMA AML 8A STUDY

ZITTOUN R SUCIU S SOLBU G WATSON M MUUS P MANDELLI F STRYCKMANS P PEETERMANS M THALER J WILLEMZE R

R. Zittoun et al., COMPARISON OF QUALITY-OF-LIFE (QOL) OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIAS (AML) IN LONG-TERM FIRST COMPLETE REMISSION (CR) AFTER BONE-MARROW TRANSPLANTATION (BMT) - ALLOGENEIC OR AUTOLOGOUS - OR INTENSIVE CHEMOTHERAPY CONSOLIDATION (ICC) - EORTC-GIMEMA AML 8A STUDY, Blood, 86(10), 1995, pp. 1718-1718

NO

Hematology

Blood → ACNP

00064971

86

10

1995

1

1718 - 1718

ISI

0006-4971(1995)86:10<1718:COQ(OP>2.0.ZU;2-P